ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628917 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628917; 2) Community: the network communities that were significantly associated with the response to NSC 628917; 3) Molecule: the relationships between components within communities and NSC 628917; 4) MDR: the compounds that were significantly associated with the NSC 628917.

NSC Compound Enrichment Correlation
NSC 113908 Null 0.0461160768969335 0.31055156
NSC 180260 Quinolinium, 1-methyl-4-[2-(2,4,5-trimethoxyphenyl)ethenyl]-, iodide 0.0461160768969335 0.27005151
NSC 208734 ACLACINOMYCIN A 0.0461160768969335 0.4042063
NSC 281613 Ethanol, 2,2'-[[4-[[[3-chloro-4-(2-phenyl-4-thiazolyl)phenyl]imino]methyl]-3-methylphenyl]imino]bis-, dimethanesulfonate (ester) 0.0461160768969335 0.47112027
NSC 3082 s-Triazine, 4,6-diamino-1-(m-bromophenyl)-1,2-dihydro-2,2-dimethyl-, hydrochloride (8CI) 0.0461160768969335 0.39404134
NSC 373355 Saframycin R 0.0461160768969335 0.31832624
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0461160768969335 0.21462866
NSC 529108 4-Fluoro-D,L-tryptophan 0.0461160768969335 0.24483014
NSC 602313 Null 0.0461160768969335 0.52255481
NSC 609815 2-Benzoylaminobenzamide, N-thiazol-2-yl- 0.0461160768969335 0.31072497
Total:106  Current:101    [First] [Prev] [Next] [Last]